News on Minitab Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Minitab Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 15:29:45 GMT en Genta Receives $2.8 Million in Non-Dilutive Proceeds from Tax Sale and Designation by EMEA as a Small Business Entityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042227&HITNO=0&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042227&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363175%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042227&HITNO=0&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042227&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363175%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: TomoTherapy Enters Australian Markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041013&HITNO=1&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041013&THISHREF=http://c.moreover.com/click/here.pl%3fz2538968963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041013&HITNO=1&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041013&THISHREF=http://c.moreover.com/click/here.pl%3fz2538968963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicexchange.com: DJO Incorporated Announces Date for Release of Fourth Quarter and Full Year 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042681&HITNO=2&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042681&THISHREF=http://c.moreover.com/click/here.pl%3fz2539501263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042681&HITNO=2&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042681&THISHREF=http://c.moreover.com/click/here.pl%3fz2539501263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Addenbrooke's Hospital Begins Treating Patients on Second TomoTherapy Cancer Treatment Systemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042849&HITNO=3&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042849&THISHREF=http://c.moreover.com/click/here.pl%3fz2539534029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042849&HITNO=3&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042849&THISHREF=http://c.moreover.com/click/here.pl%3fz2539534029%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPRLog: Report on market potential for RNA therapieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042593&HITNO=4&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042593&THISHREF=http://c.moreover.com/click/here.pl%3fz2539469163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042593&HITNO=4&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042593&THISHREF=http://c.moreover.com/click/here.pl%3fz2539469163%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042495&HITNO=5&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042495&THISHREF=http://c.moreover.com/click/here.pl%3fz2539436667%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042495&HITNO=5&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042495&THISHREF=http://c.moreover.com/click/here.pl%3fz2539436667%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042355&HITNO=6&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042355&THISHREF=http://c.moreover.com/click/here.pl%3fz2539400452%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042355&HITNO=6&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042355&THISHREF=http://c.moreover.com/click/here.pl%3fz2539400452%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042328&HITNO=7&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042328&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042328&HITNO=7&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042328&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386355%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042326&HITNO=8&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042326&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386015%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042326&HITNO=8&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042326&THISHREF=http://c.moreover.com/click/here.pl%3fz2539386015%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042273&HITNO=9&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042273&THISHREF=http://c.moreover.com/click/here.pl%3fz2539369382%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042273&HITNO=9&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042273&THISHREF=http://c.moreover.com/click/here.pl%3fz2539369382%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042214&HITNO=10&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042214&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042214&HITNO=10&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042214&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire: Research and Markets: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042212&HITNO=11&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042212&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042212&HITNO=11&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042212&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361205%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire UK: News and FDA Updates for IMS Health (NYSE:RX), Incyte (Nasdaq:INCY), Ligand (NASDAQ:LGND)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042082&HITNO=12&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042082&THISHREF=http://c.moreover.com/click/here.pl%3fz2539306442%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042082&HITNO=12&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042082&THISHREF=http://c.moreover.com/click/here.pl%3fz2539306442%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Medical News: Genta Initiates Phase 2 Study Of Tesetaxel, The Leading Clinical-Stage Oral Taxane, In Patients With Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040977&HITNO=13&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040977&THISHREF=http://c.moreover.com/click/here.pl%3fz2538953577%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040977&HITNO=13&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040977&THISHREF=http://c.moreover.com/click/here.pl%3fz2538953577%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: FDA Raises Concerns About Cell Therapeutics' Cancer Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040739&HITNO=14&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040739&THISHREF=http://c.moreover.com/click/here.pl%3fz2538856310%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040739&HITNO=14&MSIZE=869&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minitab%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040739&THISHREF=http://c.moreover.com/click/here.pl%3fz2538856310%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: